# Prem Pais

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/prem-pais/

## Facts

| Field | Value |
| --- | --- |
| Citations | 32,360 |
| Field | Blood Pressure and Hypertension Studies |
| h-index | 43 |
| i10-index | 69 |
| Last Known Institution | St. John's National Academy of Health Sciences |
| OpenAlex ID | https://openalex.org/A5082084514 |
| ORCID iD | https://orcid.org/0000-0001-5985-3137 |
| Works | 101 |

## Researcher papers

- [Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study](https://scholariq.org/papers/risk-factors-for-ischaemic-and-intracerebral-haemorrhagic-stroke-in-22-countries/)
- [Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial](https://scholariq.org/papers/dulaglutide-and-cardiovascular-outcomes-in-type-2-diabetes-rewind-a-double-blind/)
- [Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study](https://scholariq.org/papers/global-and-regional-effects-of-potentially-modifiable-risk-factors-associated/)
- [Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data](https://scholariq.org/papers/treatment-and-outcomes-of-acute-coronary-syndromes-in-india-create-a-prospective/)
- [Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial](https://scholariq.org/papers/dulaglutide-and-renal-outcomes-in-type-2-diabetes-an-exploratory-analysis-of-the/)
- [Lipid Profile, Plasma Apolipoproteins, and Risk of a First Myocardial Infarction Among Asians](https://scholariq.org/papers/lipid-profile-plasma-apolipoproteins-and-risk-of-a-first-myocardial-infarction/)
- [Design and baseline characteristics of participants in the <scp>R</scp> esearching cardiovascular <scp>E</scp> vents with a <scp>W</scp> eekly <scp>IN</scp> cretin in <scp>D</scp> iabetes ( <scp>REWIND</scp> ) trial on the cardiovascular effects of dulaglutide](https://scholariq.org/papers/design-and-baseline-characteristics-of-participants-in-the-scp-r-scp-esearching/)

## Researcher topics

- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Medication Adherence and Compliance](https://scholariq.org/topics/medication-adherence-and-compliance/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Acute Ischemic Stroke Management](https://scholariq.org/topics/acute-ischemic-stroke-management/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)

## Researcher university

- [St. John's National Academy of Health Sciences](https://scholariq.org/institutions/st-john-s-national-academy-of-health-sciences/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.